Page last updated: 2024-08-26

paxilline and Central Nervous System Neoplasm

paxilline has been researched along with Central Nervous System Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellis, SL; Benveniste, EN; Ding, Q; Gladson, CL; Grammer, JR; Han, X; Stewart, JE; Tachibana, K1

Other Studies

1 other study(ies) available for paxilline and Central Nervous System Neoplasm

ArticleYear
TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate.
    Oncogene, 2001, Nov-29, Volume: 20, Issue:55

    Topics: Animals; Astrocytoma; Blotting, Western; Cell Adhesion; Cell Size; Central Nervous System Neoplasms; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Extracellular Matrix; Fibronectins; Half-Life; Humans; Microscopy, Fluorescence; Paxillin; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Pseudopodia; Rats; Receptors, Fibronectin; RNA, Messenger; Substrate Specificity; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Up-Regulation

2001